GlassScriptPhysician profile
Sarah E Soli
NPI 1942657846
$737.31
in general payments reported to CMS, 2019-2025
16 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.55 · 2020: $17.44 · 2021: $57.54 · 2022: $83.56 · 2023: $321 · 2024: $104 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $209.74 | 2022-2025 | Amplatzer Amulet, Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $172.97 | 2020-2024 | Farxiga, Breztri |
| Novo Nordisk INC | $43.17 | 2023-2024 | Ozempic, Rybelsus |
| Lilly USA, LLC | $41.04 | 2025 | Zepbound, Mounjaro |
| Exact Sciences Corporation | $40.53 | 2023-2025 | Cologuard Collection Kit |
| Patterson Companies, INC. | $36.45 | 2021 | |
| Pfizer INC. | $33.47 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $23.60 | 2023 | Eliquis |
| Janssen Pharmaceuticals, INC | $21.87 | 2023 | Xarelto |
| Organon LLC | $19.89 | 2023 | Nexplanon |
| Glaxosmithkline, LLC. | $17.42 | 2025 | Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $17.10 | 2023 | |
| Amgen INC. | $16.94 | 2024 | Evenity, Prolia |
| Shield Therapeutics INC | $15.23 | 2025 | |
| Daiichi Sankyo INC. | $14.55 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $13.34 | 2024 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Soli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.